mg蟹大亨

      <sub id="h1lnl"></sub>

          <sub id="h1lnl"></sub>

          <sub id="h1lnl"></sub>

          <sub id="h1lnl"></sub>
          <sub id="h1lnl"></sub>

          <sub id="h1lnl"></sub>
            <sub id="h1lnl"></sub>
            <sub id="h1lnl"></sub>


            With an international view and equipped with the advantages of complete disciplines in pharmacy/traditional Chinese pharmacy, the university is developing interdisciplinary research and increasing its innovative power. The University has founded a national key lab for natural active ingredients and drug efficacy, 19 national/ministry/province-level key labs, engineering technical centers and innovative platforms for pre-clinical research and development of innovative drugs. The Drug Research Institute promotes the overall advancement of the university’s research and development of new drugs. Two organizations have been selected into Collaborative Innovation Centers of Jiangsu Universities, including Biomedical Collaborative Innovation Center and Modern Chinese Pharmacy Collaborative Innovation Center.


            Since 2006, the university has undertaken 749 national/ministry/province-level research projects and won numerous research funds, being among the top medical universities of the nation. In the nation’s Innovative New Drug major project, the university has attained 40 branch projects and 215 million Yuan funding, being No.1 among all universities of the nation.


            Our social services capabilities continue to increase and research achievements are turning into business. The Research Center for National Drug Policy and Pharmacoeconomics as well as the Lianyungang Research Institute have been established.  Cooperation agreements have been signed with a number of provincial/municipal governments, and a strategic alliance has been formed with a number of well-known domestic Pharmaceutical Groups. Since 2006, our researchers have applied for 750 patents and attained 409 of them. 11 new drugs have been approved for clinical research and 9 new drugs have been national certified. 5375 research papers have been published in core journals, in which 3100 can be retrieved from SCI and EI. Our researchers have won 1 First Prize and 3 Second Prizes of National Science and Technology Progress Award, 27 Science and Technology Progress Award at province- or ministry-level. In the last decade, 8457 cooperation agreements have been signed between CPU and pharmaceutical enterprises. 2 technology ownerships have been transferred to pharmaceutical enterprises at a price of RMB 100 million Yuan each.

                <sub id="h1lnl"></sub>

                    <sub id="h1lnl"></sub>

                    <sub id="h1lnl"></sub>

                    <sub id="h1lnl"></sub>
                    <sub id="h1lnl"></sub>

                    <sub id="h1lnl"></sub>
                      <sub id="h1lnl"></sub>
                      <sub id="h1lnl"></sub>

                      足彩app

                      大福彩票平台

                      网投网官网

                      bg大游馆

                      新大发|体育

                      在线澳门娱乐网网站

                      w88优德中文版 首页

                      乐动体育ldsports

                      1946伟德国际